Collaboration for new therapies: maximizing health and innovation

This journal publication offers insights into the following topics:

– The significant economic and health impact of innovative medicines in Europe, supporting jobs and advancing treatments across key diseases such as cancer.
– The essential role of diverse public, private, and non-profit funding mechanisms in driving innovation and fostering effective collaboration.
– The barriers within Europe’s fragmented funding and regulatory environment, emphasizing the need for coordinated policies to accelerate access to new therapies.